The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
<p>Abstract</p> <p>Background</p> <p>Elevated Glasgow Prognostic Score (GPS) has been related to poor prognosis in patients with hepatocellular carcinoma (HCC) undergoing surgical resection or receiving sorafenib. The aim of this study was to investigate the prognostic...
Main Authors: | Kinoshita Akiyoshi, Onoda Hiroshi, Imai Nami, Iwaku Akira, Oishi Mutumi, Tanaka Ken, Fushiya Nao, Koike Kazuhiko, Nishino Hirokazu, Matsushima Masato, Saeki Chisato, Tajiri Hisao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/13/52 |
Similar Items
-
A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
by: Tongyu Tong, et al.
Published: (2020-09-01) -
Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
by: Kenta Kasahara, et al.
Published: (2022-01-01) -
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
by: Yongchao Zhang, et al.
Published: (2023-01-01) -
Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
by: Lu X, et al.
Published: (2018-12-01) -
Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma
by: Ji-Feng Feng, et al.
Published: (2014-01-01)